Home > Blogs > RNA Synthesis > The Foundations of RNA Interference (RNAi)
The Foundations of RNA Interference (RNAi)

What is RNA Interference?

RNA interference (RNAi) is a highly conserved biological process that regulates gene expression by silencing specific messenger RNAs (mRNAs). Since its discovery in the late 1990s, RNAi has revolutionized molecular biology, providing researchers and clinicians with a precise tool to study gene functions and develop innovative therapies. RNAi operates through small RNA molecules, such as small interfering RNAs (siRNAs) or microRNAs (miRNAs), which guide cellular machinery to target complementary mRNA sequences. By degrading or blocking these mRNAs, RNAi effectively silences gene expression, shaping modern research and medicine.


This mechanism is integral to cellular homeostasis, influencing processes like development, stress responses, and pathogen defense. Its specificity and efficiency make it a cornerstone in functional genomics, opening doors to both basic research and therapeutic applications.


The Discovery of RNAi

The RNAi phenomenon was first identified in the nematode Caenorhabditis elegans by Andrew Fire and Craig Mello, earning them the 2006 Nobel Prize in Physiology or Medicine. Their groundbreaking work demonstrated that introducing double-stranded RNA (dsRNA) into nematode cells triggered the degradation of complementary mRNA, effectively silencing associated genes. This discovery revealed a conserved cellular mechanism across eukaryotes and provided the foundation for RNAi-based research and therapies.


Before Fire and Mello’s findings, gene silencing mechanisms were poorly understood. Their work illuminated the molecular basis of this process, leading to advancements in genetic research, biotechnology, and personalized medicine.


How Does RNA Interference Work?

RNAi operates through a multi-step process that precisely targets and silences genes. The stages include:

1. Initiation:

  • Double-stranded RNA (dsRNA) molecules, either natural or synthetic (e.g., siRNAs or shRNAs), are introduced into the cell.

  • These molecules act as the trigger for the RNAi pathway.

2. Processing by Dicer:

  • The dsRNA is recognized and cleaved by the enzyme Dicer into short siRNA fragments, approximately 21-23 nucleotides long.

3. Formation of RISC:

  • The siRNA fragments are incorporated into the RNA-induced silencing complex (RISC).

  • Within RISC, the siRNA is unwound, and the guide strand binds to complementary mRNA targets.

4. Target Binding and Silencing:

  • Guided by the siRNA, RISC binds to the mRNA, leading to its degradation or blocking its translation into proteins.

  • This targeted action ensures the silencing of specific genes, maintaining cellular control over protein production.


Intracellular mechanism of siRNA, shRNA and miRNA


Applications of RNAi in Research

RNAi has revolutionized functional genomics by enabling systematic gene silencing, which has broad applications across various fields. In research, RNAi is pivotal for gene function analysis by allowing researchers to observe phenotypic changes following gene silencing, thereby understanding the roles of individual genes. It is also widely used in drug discovery to identify novel targets and disease pathways, and in modeling diseases by creating cellular and animal models that facilitate the study of genetic disorders and therapeutic strategies. Additionally, RNAi plays a significant role in synthetic biology, where it is used to design genetic circuits for biotechnology applications.


Beyond research, the potential of RNAi in therapeutics is immense. FDA-approved RNAi-based drugs have successfully targeted rare genetic disorders by silencing disease-causing genes, demonstrating its clinical relevance. Moreover, RNAi therapies show promise in treating viral infections, cancer, and central nervous system disorders. By silencing oncogenes and specific genes in the brain, RNAi offers new avenues for targeted therapies, making it a transformative technology in the medical field.


Synbio Technologies︱RNA Interference Services

As a leading expert in the field of synthetic biology, Synbio Technologies is committed to accelerating scientific research through our RNA interference (RNAi) services and advancing the use of RNAi technology in a variety of fields.


Our customized RNA synthesis services cater to a diverse range of needs, offering siRNA products of various lengths, forms, modifications, and labels. Additionally, we provide a comprehensive selection of miRNA synthesis products, inhibitors, mimics, and negative controls. By leveraging optimized production processes and stringent quality control measures, we ensure that our RNA products are both reliable and of the highest quality.

  • Address:
    9 Deer Park Dr., Suite J-25
    Monmouth Junction, NJ 08852

This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you.
To find out more about the cookies we use, see our Privacy Policy.

Accept